Scientific Online Resource System

Scripta Scientifica Pharmaceutica

Rational use of antibiotics and the importance of pharmacists’ support

Valentina Belcheva, Evgeni Grigorov, Stefan Balkanski


There has been a growing concern related to increased antimicrobial resistance (AMR) caused by inappropriate and extensive use of antibiotics around the world. There are many factors contributing to this negative trend such as poor awareness and inadequate resources, inappropriate prescribing, uncontrolled dissemination, etc. The COVID-19 pandemic only made it worse, introducing overuse of antibiotics to prevent superinfections. And again, the pandemic is where the antimicrobial stewardship programs came to light, leading to increased focus on infection prevention rather than control with antibiotics. Pharmacists are more and more trying to control AMR. They have a significant role in coordinating their efforts with both doctors and patients in order to lower the rate of prescription checks, drugs for minor sickness, over-the-counter (OTC) issuance of drugs, overdosing, repetitive prescription usage as well as discarding antibiotics.

The article concludes that the support from pharmacists for the rational use of antibiotics is essential for the achievement of better treatment.


support, pharmacist, rational drug use, antibiotics

Full Text


Antão EM, Wagner-Ahlfs C. Antibiotikaresistenz: Eine gesellschaftliche Herausforderung [Antibiotic resistance: A challenge for society]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(5):499-506. German. doi: 10.1007/s00103-018-2726-y.

Benjamin A, Olley L, Troise O, Hughes S, Donaldson H, Sadighi A. A case of Extensively Drug Resistant (XDR) Extended Spectrum Beta-Lactamase (ESBL) typhoid fever in the Ambulatory Emergency Care (AEC) unit. Clin Infect Prac. 2021;10:100068. doi: 10.1016/j.clinpr.2021.100068.

Petrov MM. Antibiotic resistance and monitoring of antibiotic consumption in hospital settings. Annu Hosp Pharm. 2022;8(1):23-30. doi: 10.14748/ahp.v8i1.8632. (in Bulgarian).

Dimitrova Z, Getov I, Hristov E, Georgiev S, Andreevska K, Madjarov V, et al. Hospital pharmacy and the rise of clinical pharmacy in the United States. Soc Med. 2017;25(2-3):8-10. (in Bulgarian). doi: 10.14748/sm.v0i2-3.4118.

Vekov T, Kolev J, Mitev M. Hospital market in Bulgaria from the point of view of the ownership of the medical institutions (2021-2022). Med Rev (Med. Pregled). 2022:58(5):40-6. (in Bulgarian).

Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9.

Ahmad A, Patel I, Mohanta G, Balkrishnan R. Evaluation of self medication practices in rural area of town Sahaswan at northern India. Ann Med Health Sci Res. 2014;4(Suppl 2):S73-8. doi: 10.4103/2141-9248.138012.

Hawker JI, Smith S, Smith GE, Morbey R, Johnson AP, Fleming DM, et al. Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations. J Antimicrob Chemother. 2014;69(12):3423-30. doi: 10.1093/jac/dku291.

Väänänen MH, Pietilä K, Airaksinen M. Self-medication with antibiotics--does it really happen in Europe? Health Policy. 2006;77(2):166-71. doi: 10.1016/j.healthpol.2005.07.001.

Reeves DS, Finch RG, Bax RP, Davey PG, Po AL, Lingam G, et al. Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 1999;44(2):163-77. doi: 10.1093/jac/44.2.163.

Skliros E, Merkouris P, Papazafiropoulou A, Gikas A, Matzouranis G, Papafragos C, et al. Self-medication with antibiotics in rural population in Greece: a cross-sectional multicenter study. BMC Fam Pract. 2010;11:58. doi: 10.1186/1471-2296-11-58.

Lucien MAB, Carnie MF, Kilgore PE, Jean-Denis G, Fénélon N, Pierre M, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Int J Infect Dis. 2021;104:250-4. doi: 10.1016/j.ijid.2020.12.087.

Dryden M, Johnson AP, Ashiru-Oredope D, Sharland M. Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother. 2011;66(11):2441-3. doi: 10.1093/jac/dkr370.

Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459-68. doi: 10.1093/cid/ciaa530.

Price R. O'Neill report on antimicrobial resistance: funding for antimicrobial specialists should be improved. Eur J Hosp Pharm. 2016;23(4):245-7. doi: 10.1136/ejhpharm-2016-001013.

Tangcharoensathien V, Chanvatik S, Sommanustweechai A. Complex determinants of inappropriate use of antibiotics. Bull World Health Organ. 2018;96(2):141-4. doi: 10.2471/BLT.17.199687.

Dickerson LM, Mainous AG, Carek PJ. The pharmacist's role in promoting optimal antimicrobial use. Pharmacotherapy. 2000;20(6):711-23. doi: 10.1592/phco.20.7.711.35171.

Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013;10(9):4274-305. doi: 10.3390/ijerph10094274.

UK Department of Health, Department for Environment, Food and Rural Affairs. UK 5 year antimicrobial resistance strategy 2013 to 2018. London: Department of Health; 2013. Available from:

Strategy for tackling antimicrobial resistance (STAR) 2012-2017. Belfast: Department of Health, Social Services and Public Safety; 2012. Available from:

Thomsen LA, Frøkjær B, Rossing C, Herborg H. Assessment of pharmacy systems in selected countries. Identification of literature and experiences. Hillerød: Pharmakon; 2011. Available from:

‎WHO Regional Office for Europe. The role of pharmacist in encouraging prudent use of antibiotics and averting antimicrobial resistance: a review of policy and experience; 2014. Available from:

WHO, International Pharmaceutical Organization. Good pharmacy practice. Joint FIP/WHO guidelines on GPP: standards for quality of pharmacy services. The Hague: International Pharmaceutical Federation; 2012. Available from:

Gilchrist M, Wade P, Ashiru-Oredope D, Howard P, Sneddon J, Whitney L, et al. Antimicrobial stewardship from policy to practice: experiences from UK antimicrobial Pharmacists. Infect Dis Ther. 2015;4(Suppl 1):51-64. doi: 10.1007/s40121-015-0080-z.

LaPlante K, Cunha C, Morrill H, Rice L, Mylonakis E. Antimicrobial Stewardship: Principles and Practice. Publisher: CABI, 2016, 449 p. ISBN 978-178-064-439-4

Colligan C, Sneddon J, Bayne G, Malcolm W, Walker G, Nathwani D, et al. Six years of a national antimicrobial stewardship programme in Scotland: where are we now? Antimicrob Resist Infect Control. 2015;4:28. doi: 10.1186/s13756-015-0068-1.

Wickens HJ, Farrell S, Ashiru-Oredope DA, Jacklin A, Holmes A; Antimicrobial Stewardship Group of Department of Health Advisory Committee on Antimicrobial Resistance and Health Care Associated Infections (ASG-ARHAI). The increasing role of pharmacists in antimicrobial stewardship in English hospitals. J Antimicrob Chemother. 2013;68(11):2675-81. doi: 10.1093/jac/dkt241.

Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J; ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother. 2012;67 Suppl 1:i51-63. doi: 10.1093/jac/dks202.

Public Health England. Behaviour change and antibiotic prescribing in healthcare settings - literature review and behavioral analysis. Public Health England (London); 2015. Available at:

NHS Public Health England. Patient safety alert - stage two: resources addressing antimicrobial resistance through implementation of an antimicrobial stewardship programme. NHS England; 2015. Available from:

Cooke FJ, Matar R, Lawson W et al. Comment on: antibiotic stewardship — more education and regulation not more availability? J Antimicrob Chemother. 2010;65(3):598. doi: 10.1093/jac/dkp481

Cooke FJ, Holmes AH. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents. 2007;30(1):25–29. doi: 10.1016/j.ijantimicag.2007.03.003

Coll A, Kinnear M, Kinnear A. Design of antimicrobial stewardship care bundles on the high-dependency unit. Int J Clin Pharm. 2012;34(6):845–54. doi: 10.1007/s11096-012-9680-9

Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health Syst Pharm. 2010;67(9):746–9. doi: 10.2146/ajhp090259

Public Health England. Start Smart — Then Focus: antimicrobial stewardship toolkit for English hospitals. Public Health England (London), 2015. Available from:



Article Tools
Email this article (Login required)
About The Authors

Valentina Belcheva
Trakia University, Stara Zagora

Medical College

Evgeni Grigorov
Medical University of Varna

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy

Stefan Balkanski
Bulgarian Pharmaceutical Union

Font Size